December 12, 2024 54 Novel Drugs Await FDA Review An analysis published in the American Journal of Health-System Pharmacy provides an overview of the potential next wave of pharmaceuticals. Conexiant
December 09, 2024 Do SGLT2i, GLP-1 RAs Cut Pneumonia, Sepsis Risk? In the largest real-world study to date, GLP-1 receptor agonists reduced pneumonia risk by 40% in type 2 diabetes patients. Conexiant
December 02, 2024 Benralizumab Cuts Respiratory Exacerbation Failures "These results offer a new way of treating eosinophilic endotypes of asthma and COPD exacerbations." Conexiant